Evidence map›Paper›PMID 31532007›Full record

Trial reportInternational journal of urology : official journal of the Japanese Urological Association2019

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer.

Sahoko Ninomiya, Takashi Kawahara, Tomoyuki Tatenuma, Yasuhide Miyoshi, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura

Abstract readClinical TrialComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in International journal of urology : official journal of the Japanese Urological Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sahoko NinomiyaDepartments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Takashi KawaharaDepartments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Tomoyuki TatenumaDepartments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Yasuhide MiyoshiDepartments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Hiroshi MiyamotoDepartments of Pathology and Laboratory Medicine, Urology, and Oncology, University of Rochester Medical Center, Rochester, New York, USA.
Masahiro YaoDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Hiroji UemuraDepartments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAgedAged, 80 and overAntineoplastic AgentsBenzamidesCapsulesDeglutitionDose-Response Relationship, DrugFatigueHealthy VolunteersHumansMaleNitrilesPatient PreferencePhenylthiohydantoinPlacebosAntineoplastic AgentsBenzamidesCapsulesenzalutamideNitrilesPhenylthiohydantoinPlacebosTabletsVitamins

Identifiers

PMID31532007
PMCPMC6916586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.